
Hepatologist

No OPD information available
Hepatitis
Hepatitis C
Ascites
Cirrhosis
Hepatitis B
Liver Cancer
Liver Failure
Spontaneous Bacterial Peritonitis
Stephen Pianko is a male healthcare provider who helps people with liver and related health issues like Hepatitis, Cirrhosis, and Liver Cancer. He is skilled in treating conditions such as Ascites, Liver Failure, and Spontaneous Bacterial Peritonitis.
Stephen Pianko works closely with his patients to understand their health needs and provide the best care possible. He listens to their concerns and explains things in a way that is easy to understand. Patients trust him because he shows compassion and takes the time to answer their questions.
To stay updated with the latest medical knowledge, Stephen Pianko regularly reads scientific journals and attends conferences. This helps him provide the most effective treatments based on the newest research findings.
Stephen Pianko collaborates with other medical professionals to ensure his patients receive comprehensive care. He values teamwork and believes that working together leads to better outcomes for patients.
Through his work, Stephen Pianko has positively impacted many patients' lives by improving their health and quality of life. His dedication to providing excellent care has earned him respect from both patients and colleagues.
One of Stephen Pianko's notable publications is a case report titled "A Diagnostic Dilemma of Prevertebral Abscess Versus Food Bolus on Lateral Neck X-Ray," published in Cureus. He has also been involved in clinical trials to evaluate new treatments for liver conditions like Nonalcoholic Steatohepatitis.
In summary, Stephen Pianko is a dedicated healthcare provider who is committed to helping patients with liver-related health issues. His expertise, compassionate care, and commitment to staying informed on the latest medical advancements make him a trusted and respected professional in his field.
Enrollment Status: Terminated
Published: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
